Top

European Archives of Oto-Rhino-Laryngology

Published in:

01-07-2011 | Miscellaneous

Increased seroprevalence of Toxoplasma gondii in a population of patients with Bell’s palsy: a sceptical interpretation of the results regarding the pathogenesis of facial nerve palsy

Authors: Maria Riga, G. Kefalidis, A. Chatzimoschou, G. Tripsianis, S. Kartali, H. Gouveris, M. Katotomichelakis, V. Danielides

Published in: European Archives of Oto-Rhino-Laryngology | Issue 7/2011

Abstract

Facial nerve oedema and anatomical predisposition to compression within the fallopian tube seem to be the only generally accepted facts in the pathophysiology of Bell’s palsy. Several infectious causes have been suggested as possible triggers of this oedema. Most of the suggested pathogens have been associated with facial nerve lesions during latent infections, reinfections or endogenous reactivations. The aim of this study was to investigate the seroprevalence of three such pathogens Toxoplasma gondii, Epstein–Barr virus (EBV) and cytomegalovirus (CMV) in a population of patients with facial nerve palsy. Fifty-six patients with Bell’s palsy were included in the study. A group of 25 individuals with similar age and gender distribution was used as control. Seropositivity for T. gondii, EBV viral capsid antigen (VCA) and CMV-specific IgM and IgG antibodies was investigated 2–5 days after the onset of the palsy. Comparisons for both IgM and IgG antibodies against T. gondii attributed significantly higher seroprevalence in the patients’ group than in the control group (p = 0.024 and 0.013, respectively). The respective examinations for EBV and CMV attributed no significant results. The roles of EBV and CMV in the pathogenesis of Bell’s palsy were not confirmed by this study. However, a significantly higher seroprevalence of IgM- and IgG-specific T. gondii antibodies was detected in patients with Bell’s palsy when compared to healthy controls. The possibility that facial nerve palsy might be a late complication of acquired toxoplasmosis may need to be addressed in further studies.

Traavik T, Storvold G, Sundsfjord A, Lund S, Mair IW (1983) Peripheral facial palsy and coincidental cytomegalovirus infection or reactivation. Scan J Infect Dis 15:233–238

Grose C, Feorino PM, Dye LA, Rand J (1973) Bell’s palsy and infectious mononucleosis. Lancet 2:231–232PubMedCrossRef

Njoo FL, Werthheim-van Dillen P, Devriese PP (1988) Serology in facial paralysis caused by clinically presumed herpes zoster infection. Arch Othorhinolaryngol 245:230–237CrossRef

Hydén D, Roberg M, Forsberg P, Fridell E, Frydén A, Linde A, Ödkvist L (1993) Acute ‘idiopathic’ peripheral facial palsy: clinical, serological, and cerebrospinal fluid findings and effects of corticosteroids. Am J Otolaryngol 14:179–186PubMedCrossRef

Jamal GA, Al-Husaini A (1983) Bell’s palsy and infection with rubella virus. J Neurol Neurosurg Psychiatry 46:678–680PubMedCrossRef

Brown MM, Thompson A, Goh BT, Forster GE, Swash M (1988) Bell’s palsy and HIV infection. J Neurol Neurosurg Psychiatry 51:425–426PubMedCrossRef

Nakamura K, Yanagihara N (1998) Neutralization antibody to herpes simplex virus type 1 in Bell’s palsy. Ann Otol Rhinol Laryngol 137:18–21

Häusler M, Ramaekers VT, Doenges M, Schweizer K, Ritter K, Schaade L (2002) Neurological complications of acute and persistent Epstein–Barr virus infection in paediatric patients. J Med Virol 68(2):253–263PubMedCrossRef

Roberg M, Ernerudh J, Forsberg P, Fridell E, Frydén A, Hydén D, Linde A, Odkvist L (1991) Acute peripheral facial palsy: CSF findings and etiology. Acta Neurol Scand 83(1):55–60PubMedCrossRef

10.

Couvreur J, Thulliez P (1996) Acquired toxoplasmosis of ocular or neurologic site: 49 cases. Presse Med 25(9):438–442PubMed

11.

Takasaki T, Higashikawa M, Motoyama S, Sugita K, Kurane I (1998) Serum antibodies to human herpesvirus 7, human herpesvirus 6 and cytomegalovirus in patients with idiopathic facial nerve palsy or sudden deafness. J Laryngol Otol 112(7):617–621PubMedCrossRef

12.

Fisch U (1981) Surgery for Bell’s palsy. Arch Otolaryngol 107:1PubMed

13.

Schwaber MK, Larson TC III, Zealear DL, Creasy J (1990) Gadolinium-enhanced magnetic resonance imaging in Bell’s palsy. Laryngoscope 100:1264–1269PubMedCrossRef

14.

Engström M, Thuomas K-Å, Naeser P, Stelberg E, Jonsson L (1993) Facial nerve enhancement in Bell’s palsy demonstrated by different gadolinium-enhanced magnetic resonance imaging techniques. Arch Otolaryngol Head Neck Surg 119:221–225PubMed

15.

Sartoretti-Schefer S, Brändle P, Wichmann W, Valavanis A (1996) Intensity of MR contrast enhancement does not correspond to clinical and electroneurographic findings in acute inflammatory facial nerve palsy. AJNR Am J Neuroradiol 17(7):1229–1236PubMed

16.

Yetiser S, Kazkayas M, Altinok D, Karadeniz Y (2003) Magnetic resonance imaging of the intratemporal facial nerve in idiopathic peripheral facial palsy. Clin Imaging 27(2):77–81PubMedCrossRef

17.

Kefalidis G, Riga M, Argyropoulou P, Katotomichelakis M, Gouveris C, Prassopoulos P, Danielides V (2010) Is the width of the labyrinthine portion of the fallopian tube implicated in the pathophysiology of Bell’s palsy? A prospective clinical study using computed tomography. Laryngoscope 120(6):1203–1207PubMed

18.

Bibas T, Jiang D, Gleeson J (2008) Disorders of the facial nerve. In: Gleeson M (ed) Scott-Brown’s Otorhinolaryngology head and neck surgery, 7th edn. Edward Arnold, London, pp 3883–3886

19.

Morgan M, Moffat M, Ritchie L, Collacott I, Brown T (1995) Is Bell’s palsy a reactivation of varicella zoster virus? J Infect 30(1):29–36PubMedCrossRef

20.

Roach ES, Zimmerman CF, Troost BT, Weaver RG (1985) Optic neuritis due to acquired toxoplasmosis. Pediatr Neurol 1(2):114–116PubMedCrossRef

21.

Schlottmann A, Kleemann D, Kranz K, Schmal G (1996) Sudden deafness and increased toxoplasmosis IgM titer. Laryngorhinootologie 75(11):687–690PubMedCrossRef

22.

Noorbakhsh S, Memari F, Farhadi M, Tabatabaei A (2008) Sensorineural hearing loss due to Toxoplasma gondii in children: a case–control study. Clin Otolaryngol 33(3):269–273PubMedCrossRef

23.

Fagard R, Van Tan H, Creuzet C, Pelloux H (1999) Differential development of Toxoplasma gondii in neural cells. Parasitol Today 15(12):504–507PubMedCrossRef

24.

Katholm M, Johnsen NJ, Siim C, Willumsen L (1991) Bilateral sudden deafness and acute acquired toxoplasmosis. J Laryngol Otol 105(2):115–118PubMedCrossRef

25.

De Paschale M, Agrappi C, Clerici P, Mirri P, Manco MT, Cavallari S, Viganò EF (2008) Seroprevalence and incidence of Toxoplasma gondii infection in the Legnano area of Italy. Clin Microbiol Infect 14(2):186–189PubMed

26.

Nowakowska D, Stray-Pedersen B, Spiewak E, Sobala W, Małafiej E, Wilczyński J (2006) Prevalence and estimated incidence of Toxoplasma infection among pregnant women in Poland: a decreasing trend in the younger population. Clin Microbiol Infect 12(9):913–917PubMedCrossRef

27.

Diza E, Frantzidou F, Souliou E, Arvanitidou M, Gioula G, Antoniadis A (2005) Seroprevalence of Toxoplasma gondii in northern Greece during the last 20 years. Clin Microbiol Infect 11(9):719–723PubMedCrossRef

28.

Evengård B, Petersson K, Engman ML, Wiklund S, Ivarsson SA, Teär-Fahnehjelm K, Forsgren M, Gilbert R, Malm G (2001) Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect 127(1):121–127PubMedCrossRef

29.

Maddern BR, Werkhaven J, Wessell H, Yunis E (1991) Infectious mononucleosis with airway obstruction and multiple cranial nerve paresis. Otol Head Neck Surg 104:529–532

30.

Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A (1993) Interleukin 12 is required for the T-lymphocyte-independent induction of interferon by an intracellular parasite and induces resistance in T-cell deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115–6119PubMedCrossRef

31.

Alexander J, Scharton-Kersten TM, Yap G, Roberts CW, Liew FY, Sher A (1997) Mechanisms of innate resistance to Toxoplasma gondii infection. Phil Trans R Lond B 352:1355–1359CrossRef

32.

Wallace GR, Stanford MR (2008) Immunity and Toxoplasma retinochoroiditis. Clin Exp Immunol 153(3):309–315PubMedCrossRef

33.

Courret N, Darche S, Sonigo P, Milon G, Buzoni-Gâtel D, Tardieux I (2006) CD11c- and CD11b expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 107:309–316PubMedCrossRef

34.

Lambert H, Hitziger N, Dellacasa I, Svensson M, Barragan A (2006) Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination. Cell Microbiol 81:1611–1623CrossRef

35.

Lu F, Huang S, Kasper LH (2004) CD4+ T cells in the pathogenesis of murine ocular toxoplasmosis. Infect Immun 72:4966–4972PubMedCrossRef

36.

Birner P, Gatterbauer B, Drobna D, Bernheimer H (2000) Molecular mimicry in infectious encephalitis and neuritis: binding of antibodies against infectious agents on Western blots of human nervous tissue. J Infect 41(1):32–38PubMedCrossRef

37.

Lappalainen M, Hedman K (2004) Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity. Ann Ist Super Sanita 40(1):81–88PubMed

38.

Roberts A, Hedman K, Luyasu V, Zufferey J, Bessières J-H, Blatz R-M, Candolfi E, Decoster A, Enders G, Gross U, Guy E, Hayde M, Ho-Yen D, Johnson J, Lécolier B, Naessens A, Pelloux H, Thulliez P, Petersen E (2001) Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis 20:467–474PubMedCrossRef

39.

Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, Hedman K, Remington JS (1997) False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol 35(1):174–178PubMed

40.

Rothova A, van Knapen F, Baarsman GS, Kruit PJ, Loewer-Sieger DH, Kijlstra A (1986) Serology in ocular toxoplasmosis. Br J Ophthalmol 70:615–622PubMedCrossRef

41.

Holliman RE, Stevens PJ, Duffy KT, Johnson JD (1991) Serological investigation of ocular toxoplasmosis. Br J Ophthalmol 75:353–355PubMedCrossRef

42.

Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A (2002) Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 109(5):869–878PubMedCrossRef

43.

Hughes GB, Barna BP, Kinney SE, Goren H, Sweeney PJ, Valenzuela R, Calabrese LH, Tucker HM (1986) Immune reactivity in Bell’s palsy. Otolaryngol Head Neck Surg 95(5):586–588PubMed

44.

Jonsson L, Sjöberg O, Thomander L (1988) Activated T cells and Leu-7+ cells in Bell’s palsy. Acta Otolaryngol 105(1–2):108–113PubMedCrossRef

45.

Morgan M, Nathwani D (1992) Facial palsy and infection: the unfolding story. Clin Infect Dis 14:263–271PubMedCrossRef

46.

Engström M, Berg T, Stjernquist-Desatnik A, Axelsson S, Pitkäranta A, Hultcrantz M, Kanerva M, Hanner P, Jonsson L (2008) Prednisolone and valaciclovir in Bell’s palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol. 7(11):993–1000PubMedCrossRef

Title: Increased seroprevalence of Toxoplasma gondii in a population of patients with Bell’s palsy: a sceptical interpretation of the results regarding the pathogenesis of facial nerve palsy
Authors: Maria Riga
G. Kefalidis
A. Chatzimoschou
G. Tripsianis
S. Kartali
H. Gouveris
M. Katotomichelakis
V. Danielides
Publication date: 01-07-2011
Publisher: Springer-Verlag
Published in: European Archives of Oto-Rhino-Laryngology / Issue 7/2011
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-011-1499-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Increased seroprevalence of Toxoplasma gondii in a population of patients with Bell’s palsy: a sceptical interpretation of the results regarding the pathogenesis of facial nerve palsy

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2011

Subjective visual vertical in erect/supine subjects and under microgravity: effects of lower body negative pressure

Incidental extirpation of the parathyroid glands at thyroid surgery: risk factors and post-operative hypocalcemia

Intracochlear perfusion of leupeptin and z-VAD-FMK: influence of antiapoptotic agents on gunshot-induced hearing loss

Sling arytenoid adduction

Hearing loss in divers: a 6-year prospective study

Long-term results of palatal implants for obstructive sleep apnea